These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. Impact on clinical practice of updated guidelines on iodinated contrast material: CINART. Nijssen EC; Nelemans PJ; Rennenberg RJ; van der Molen AJ; van Ommen GV; Wildberger JE Eur Radiol; 2020 Jul; 30(7):4005-4013. PubMed ID: 32107605 [TBL] [Abstract][Full Text] [Related]
25. Corrigendum regarding the article by Song et al. entitled 'Renal replacement therapy for prevention of contrast-induced acute kidney injury: a meta-analysis of randomized controlled trials'. Cruz DN; Perazella MA Am J Nephrol; 2011; 34(2):173; author reply 174. PubMed ID: 21757890 [No Abstract] [Full Text] [Related]
26. Controversies in Contrast Material-induced Acute Kidney Injury: Closing in on the Truth? McDonald RJ; McDonald JS; Newhouse JH; Davenport MS Radiology; 2015 Dec; 277(3):627-32. PubMed ID: 26599922 [No Abstract] [Full Text] [Related]
27. Cost of screening strategies for kidney disease before intravenous contrast administration. Moos SI; de Weijert RS; Nagan G; Stoker J; Bipat S Neth J Med; 2014 Jun; 72(5):271-80. PubMed ID: 24930461 [TBL] [Abstract][Full Text] [Related]
28. Cystatin C and contrast-induced acute kidney injury. Briguori C; Visconti G; Rivera NV; Focaccio A; Golia B; Giannone R; Castaldo D; De Micco F; Ricciardelli B; Colombo A Circulation; 2010 May; 121(19):2117-22. PubMed ID: 20439784 [TBL] [Abstract][Full Text] [Related]
29. Renal insufficiency following contrast media administration trial II (REMEDIAL II): RenalGuard system in high-risk patients for contrast-induced acute kidney injury: rationale and design. Briguori C; Visconti G; Ricciardelli B; Condorelli G; EuroIntervention; 2011 Apr; 6(9):1117-22, 7. PubMed ID: 21518686 [TBL] [Abstract][Full Text] [Related]
30. The effect of renin-angiotensin-aldosterone system blockade on contrast-induced acute kidney injury: a propensity-matched study. Rim MY; Ro H; Kang WC; Kim AJ; Park H; Chang JH; Lee HH; Chung W; Jung JY Am J Kidney Dis; 2012 Oct; 60(4):576-82. PubMed ID: 22658321 [TBL] [Abstract][Full Text] [Related]
31. Contrast-induced nephropathy: pathogenesis and new therapeutic options for prevention. Ortega LM; Harmouch I; Nayer A Am J Ther; 2015; 22(6):469-76. PubMed ID: 25470612 [TBL] [Abstract][Full Text] [Related]
32. Subclinical and clinical contrast-induced acute kidney injury: data from a novel blood marker for determining the risk of developing contrast-induced nephropathy (ENCINO), a prospective study. Akrawinthawong K; Ricci J; Cannon L; Dixon S; Kupfer K; Stivers D; Alexander P; David S; McCullough PA Ren Fail; 2015 Mar; 37(2):187-91. PubMed ID: 25519207 [TBL] [Abstract][Full Text] [Related]
33. Impact of Serum Albumin Levels on Contrast-Induced Acute Kidney Injury in Patients With Acute Coronary Syndromes Treated With Percutaneous Coronary Intervention. Murat SN; Kurtul A; Yarlioglues M Angiology; 2015 Sep; 66(8):732-7. PubMed ID: 25260710 [TBL] [Abstract][Full Text] [Related]